HPK1 mRNA and protein levels were observed to be significantly decreased in CD4+ T cells of patients with systemic lupus erythematosus (SLE), contributing to the overactivation of T and B cells in SLE [6], supporting an important role of HPK1 in the maintenance of peripheral tolerance. Here, MAP4K1 is linked to systemic lupus erythematosus.